A Time-Sensitive Stansberry Teaser

by Travis Johnson, Stock Gumshoe | May 29, 2009 10:35 am

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/reviews/inside-strategist/a-time-sensitive-stansberry-teaser/


30 responses to “A Time-Sensitive Stansberry Teaser”

  1. Garyshipman says:

    Is there a board where we can immediately post teases so that we can all either divulge the answer or work on the problem? I have been exceptionally underwhelmed by the regular gumshoe boards. Plus there are a ton of profitable teases that I don’t ever receive probably because I am a subscriber to about everything agora puts out.

    cheers,
    d

  2. acutinsiniarp says:

    Really appreciate the work you do at gumshoe, very interesting reading and good commentary. There are so many teasers out there that it is hard to keep up with, you do a great job, thanks. There were a couple in Stansberry’s S&A Digest this morning, as it seems there is every day. I subscribe to their Oil Report, also to Doody’s Gold Stock Analyst, plus Chris Weber’s and a few others. I would love to see a site where we could quickly reference the new teases that constantly come across, however, understanding the time commitment would be astronomical and you would have so many to do that doing a really thorough job would be next to impossible, plus would we have enough time to read all that information? Probably not, and that is why I am currently unsubscribing to many who just use my subscription as an excuse to constantly flood my in box with teaser ads to more expensive services they or their cronies offer.

  3. Garyshipman says:

    write the write……write the right :>

  4. RonaldNYW says:

    It looks to me like Damon has a good idea about a board to post to. If the Stock Gumshoe made it a regular
    place to check for the irregular customers, he too would benefit by word of mouth advertising amoung his readers and more of them would probably become irregulars.

  5. maebecd says:

    Hey Damon!

    Name another site where you get free or almost free (IREGULARS) info?

    Maybe you should start your own site?

    Some of us appreciate you Travis – others would complain if they were hung with a new rope!

    Cool Soupy

  6. tflorida says:

    Thank you for the timely review. I just recieived that teaser email. I actively subscribe to their 12% letter because I have done pretty well with it.

    OTOH, I have canceled so many of Stansbury or Agoro Financial(an afilliate of Stansbury) subscriptions within 2 days of paying for them that I have lost count.

    The reason is that I look at what the particular service is about and most of the time, it looks to me like a risky or outright dumb idea. For instance,. they had one just last week where they were going to email you with a recommendation of a stock that was going to skyrocket.

    Guess what? They sent the email at 10:30 and it sure did skyrocket. It did 90% of it’s gains from 9:30 until 11:00. What good is sending a speculative stock tip an hour AFTER the market opened – thats dumb.

  7. saltee101 says:

    Verifone may be a short term money maker after the earnings are released on Tuesday, but I think it’s a poor long term investment at its current price of $7.63 and its current financial condition. I looked at 2 Form 4’s on the SEC website that showed that CEO Doug Bergeron bought 115,000 shares of Verifone in May for between $6.14 and $6.50 per share. Maybe he thinks the price per share will go up after the earnings are released?
    As a long term investment:
    Verifone had a loss of -$6.80 per share the last year. Most of that loss was due to “unusual expense.” There was a huge writedown of “goodwill” on the balance sheet that was close in amount to the “unusual expense.” So without doing more research, I think most of the loss Verifone had for the last 4 quarters was a goodwill writedown, which is a paper loss. That’s good news. The company had an operating cash flow per share of $0.28, so it is generating some cash. The company has a negative book value. Its liabilities exceed assets by $40 million. Its retained earnings is -$686 million.
    My conclusion:
    Based on weak operating cash flows and a negative book value, this company isn’t worth $7.63 per share. I think it may be worth around $3 per share.

  8. CreativeAcrobate says:

    Ouch, PAY is down big time before and after the earnings announcement.. I missed the pop in the AM to unload this one. Porter recommended this turkey?

  9. CreativeAcrobate says:

    if it drops anymore, its a sell tommorow.. If it stays put, I’ll give it a couple weeks to sell on a gap up day..

    ..

  10. constra says:

    Insider Strategist by Stannsberry says this is CardioNet Inc. symbol { beat ).Own by June 2nd for 50% gain on the June 2nd announcement. Never happened!! They use this as a come on to use your money. I alse would like a sight to expose this for what it really is.

  11. brenda says:

    PAY is actually doing decently, considering the big runup to the earnings announcement. No 50% shot in a matter of days, but in the past two earnings cycles the big returns came over a substantially longer time period after earnings were announced. I obviously have no idea whether or not the stock will continue to climb, but it’s interesting that — after the massive runup last week — it didn’t sell off dramatically and give back all those gains.

  12. CreativeAcrobate says:

    Sold it for a small loss..
    Thanks Porter!

  13. constra says:

    My option contracts went out on stop limit last Fri May 29, I was discussted at .30 a share but looking at the price today I’m now glad that BEAT is behind me. So much for Porter S.

  14. Carroabsves says:

    re BEAT; yet another reminder that when these guys tout the potential big move ; sometimes it goes the wrong way. BEAT gapped from 16 to 10.
    Citigroup’s Amit Bhalla, who lowered the company to hold from buy, said the changes were surprising in part because CardioNet recently issued long-term guidance. The downgrade comes because “management’s credibility and uncertainty over reimbursement rates will remain a near-term overhang, in our view,” Bhalla said.

    CardioNet said it now expects earnings of 30 cents to 35 cents a share and revenue of $156 million to $160 million this year, which compares with its April forecast for 69 cents to 73 cents and $170 million to $175 million, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.